Loading…
Loading…
RWOD (Redwoods Acquisition Corp.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
NEW YORK , June 24, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or the "Company") announces the Company's common shares and warrants will begin trading on the NASDAQ Global Market under the ticker symbols "WENA" and "WENAW", respectively.
ANEW MEDICAL, INC.'s shares and warrants are expected to begin trading on the Nasdaq Global Market under the tickers “WENA” and “WENAW”, respectively.
Redwoods Acquisition (NASDAQ: RWOD ) stock is in the news Friday as after the special purpose acquisition company (SPAC) got approval from shareholders for its merger with Anew Medical. Let's get into everything traders need to know about the SPAC merger between Redwoods Acquisition and Anew Medical below!
Redwoods Acquisition (NASDAQ: RWOD , NASDAQ: RWODU ) stock is rocketing higher on Friday alongside details from a recent shareholder meeting. The shareholder meeting took place on April 12 and saw investors in Redwoods Acquisition vote on proposals for its merger with Anew Medical.
NEW YORK , March 4, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases.